A New Hypromellose Capsule For Optimum Formulation Of Pharmaceutical Dosage Forms

Hypromellose (HPMC) capsules were originally formulated with a secondary gelling agent. This agent can delay dissolution in some circumstances and lead to unwanted issues during product development.

In this article, we discuss the rationale for developing Capsugel's Vcaps® Plus capsules without a gelling agent. We also describe how these capsules – now in use at many major pharmaceutical companies to encapsulate their existing over-the-counter [OTC] products and New Chemical Entities [NCEs] – can optimize product performance and improve product stability, as well as reduce development timelines.

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

or

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Please tell us more about you so that we can customize our newsletters to your specific interests:

Get the latest articles from Pharmaceutical Online delivered to your inbox.